Zero tolerance for catheter-related bloodstream infections: The unnegotiable objective

Infection Control and Hospital Epidemiology

Volumn 29, Issue 10, 2008, Pages 951-953

  Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; SULFADIAZINE SILVER; MINOCYCLINE; RIFAMPICIN;

CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DEVICE INFECTION; FEMORAL VEIN; HEMODIALYSIS; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; MORBIDITY; MORTALITY; NOTE; ASEPSIS; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; EQUIPMENT; INDWELLING CATHETER; METHODOLOGY; MICROBIOLOGY;

ASEPSIS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; CROSS INFECTION; EQUIPMENT CONTAMINATION; HUMANS; MINOCYCLINE; RIFAMPIN; SILVER SULFADIAZINE;

EID: 53549086920     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/591939     Document Type: Note

References (15)

1. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007; 7:645-657.
2. Lee D, Jung K, Choi Y. The use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008; 29:947-950 (in this issue).
3. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertions. Infect Control Hosp Epidemiol 1994; 15(4 Pt 1):231-238.
4. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU (published correction appears in N Engl J Med 2007; 356:2660). N Engl J Med 2006; 355:2725-2732.
5. Ramritu P, Halton K, Collignon P, et al. A systemic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008; 36:104-117.
6. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007; 59:359-369.
7. Crnich CJ, Maki DG. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. Clin Infect Dis 2004; 38: 1287-1292.
8. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters. Potential financial implications. Chest 2003; 124:275-284.
9. Chatzinikolaou I, Hanna H, Graviss L, et al. Clinical experience with minocycline and rifampin-impregnated central venous cathetersin bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003; 24:961-963.
10. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial (published correction appears in J Clin Oncol 2005; 23:3652). J Clin Oncol 2004; 22:3163-3171.
11. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005; 143:570-580.
12. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173:418-424.
13. Marik PE, Abraham G, Careau P, Varon J, Fromm RE Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27:1128-1131.
14. Raad II, Darouiche RO, Hachem R, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 1998; 26:219-224.
15. Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission - worldwide, January 2007-April 2008. MMWR Morb Mortal Wkly Rep 2008; 57:489-494.